Association between sacubitril/valsartan initiation and real‐world health status trajectories over 18 months in heart failure with reduced ejection fraction

AIMS: Improving the health status (symptoms, function, and quality of life) of patients with heart failure with reduced ejection fraction (HFrEF) is a primary treatment goal. Angiotensin receptor neprilysin inhibitors (ARNI) improve short‐term health status in clinical practice, but the sustainabili...

Descripción completa

Detalles Bibliográficos
Autores principales: Thomas, Merrill, Khariton, Yevgeniy, Fonarow, Gregg C., Arnold, Suzanne V., Hill, Larry, Nassif, Michael E., Chan, Paul S., Butler, Javed, Thomas, Laine, DeVore, Adam D., Hernandez, Adrian F., Albert, Nancy M., Patterson, J. Herbert, Williams, Fredonia B., Spertus, John A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Original Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318450/
https://www.ncbi.nlm.nih.gov/pubmed/33932120
http://dx.doi.org/10.1002/ehf2.13298

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8318450/
https://www.ncbi.nlm.nih.gov/pubmed/33932120
http://dx.doi.org/10.1002/ehf2.13298

Ejemplares similares